Erwin Mahajan Revised's Insider Trades & SAST Disclosures
Erwin Mahajan Revised's most recent trade in Brooks Laboratories Ltd. was a Acquisition of 70,970 Equity Shares done at an average price of Rs. 75 . Disclosure was reported to the exchange on Aug. 31, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Erwin Mahajan Revised in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brooks Laboratories | Erwin Mahajan (Revised) | Promoter Group | Acquisition | 31 Aug 2023 | 70,970 | 1,206,490 (4.60%) | 0.27% | 75 | 5,322,750 | 30 Aug 2023 30 Aug 2023 |
Insider Trading | Equity Shares | Public Right |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.